These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32710269)

  • 61. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.
    Wang J; Li D; Zhou Q; Wiltse A; Zand MS
    Front Immunol; 2021; 12():696370. PubMed ID: 34386006
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of a Lateral Flow Immunoassay COVIDTECH
    Exinger J; Hartard C; Lafferrière F; Fenninger C; Charbonnière LJ; Jeulin H
    Jpn J Infect Dis; 2022 Jul; 75(4):334-340. PubMed ID: 34980703
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.
    Demey B; Daher N; François C; Lanoix JP; Duverlie G; Castelain S; Brochot E
    J Infect; 2020 Aug; 81(2):e6-e10. PubMed ID: 32389784
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
    Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
    Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
    [No Abstract]   [Full Text] [Related]  

  • 65. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum IgA, IgM, and IgG responses in COVID-19.
    Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
    Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
    [No Abstract]   [Full Text] [Related]  

  • 67. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.
    Pérez-García F; Pérez-Tanoira R; Romanyk J; Arroyo T; Gómez-Herruz P; Cuadros-González J
    J Clin Virol; 2020 Aug; 129():104473. PubMed ID: 32504945
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SARS-CoV-2 IgG antibody responses in New York City.
    Reifer J; Hayum N; Heszkel B; Klagsbald I; Streva VA
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115128. PubMed ID: 32777699
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
    Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
    PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protective humoral immunity in SARS-CoV-2 infected pediatric patients.
    Zhang Y; Xu J; Jia R; Yi C; Gu W; Liu P; Dong X; Zhou H; Shang B; Cheng S; Sun X; Ye J; Li X; Zhang J; Ling Z; Ma L; Wu B; Zeng M; Zhou W; Sun B
    Cell Mol Immunol; 2020 Jul; 17(7):768-770. PubMed ID: 32382126
    [No Abstract]   [Full Text] [Related]  

  • 72. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals.
    Wang H; Ai J; Loeffelholz MJ; Tang YW; Zhang W
    Emerg Microbes Infect; 2020 Dec; 9(1):2200-2211. PubMed ID: 32962560
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).
    Guo L; Ren L; Yang S; Xiao M; Chang D; Yang F; Dela Cruz CS; Wang Y; Wu C; Xiao Y; Zhang L; Han L; Dang S; Xu Y; Yang QW; Xu SY; Zhu HD; Xu YC; Jin Q; Sharma L; Wang L; Wang J
    Clin Infect Dis; 2020 Jul; 71(15):778-785. PubMed ID: 32198501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti SARS-CoV-2 antibodies monitoring in a group of residents in a long term care facility during COVID-19 pandemic peak.
    Carta M; Bragagnolo L; Tramarin A; Barzon E; Cappelletti A; Pascarella M; Forner L; Meneghini MG; Tripodi C; Rassu M; Giavarina D
    Diagnosis (Berl); 2020 Nov; 7(4):395-400. PubMed ID: 32827394
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
    Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
    New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

  • 78. EDTA-K
    Hu X; Wu C; Situ B; Tian P; An T; Li Q; Pan W; Zhang R; Yang B; Sun D; Hu Y; Wang Q; Zheng L
    Int J Nanomedicine; 2021; 16():715-724. PubMed ID: 33542626
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs.
    Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P
    Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.
    Liu X; Zheng X; Liu B; Wu M; Zhang Z; Zhang G; Su X
    Aging (Albany NY); 2020 Jul; 12(13):12432-12440. PubMed ID: 32628642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.